Eevia Health Plc receives new sales order for Feno-Sambucus™ from Australia for 450 KSEK / 40 KEUR

Eevia Health ("Eevia" or "The Company") received a 450 KSEK / 40 KEUR sales order for the Feno-Sambucus™ from its Australian distributor Ingredient Plus. The order is the second order from an Australian brand owner.

The end customer is a well-established player within innovative complementary medicines in Australia, marketing and selling a targeted product range, combining nutrients, herbal, and other ingredients. It is a leading supplier of traditional remedies which are available in over five thousand pharmacies and health food stores across Australia. Their focus is on mums' and children´s health solutions. The end customer uses the elderberry ingredients from Eevia in new liquid nutraceutical formulations.

Eevia Health Plc is a leading health ingredient manufacturer from Finland and is currently the largest manufacturer of elderberry extract in the world. The brand holder chose the Eevia extract Feno-Sambucus because it has a better nutritional composition compared to competitors due to Eevia's purification technology. For the same reason, Eevia offers a better taste profile and solubility. The order is related to the launch of new products by the brand owner. Eevia expects repeat orders in the future.

Ingredient Plus is a leading and independent Australian distributor working with Eevia Health. It has a strong position in Australia also covering other territories in the Asia-Pacific Region across key strategic markets.

Seinäjoki, Finland 18.4.2023

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          
Email: [email protected]                      
Telephone: +358 400 22 5967   


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands use the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]